Article Information
PubMed
Print ISSN
Online ISSN
History
- Received March 8, 2011
- Accepted October 3, 2011
- Published online December 16, 2011.
Article Versions
- Earlier version (October 5, 2011 - 09:03).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2012 by The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Brianne S. Raccor,
- Adam J. Claessens,
- Jean C. Dinh,
- Julie R. Park,
- Douglas S. Hawkins,
- Sushma S. Thomas,
- Karen W. Makar,
- Jeannine S. McCune and
- Rheem A. Totah
- Departments of Pharmacy (B.S.R., A.J.C., J.S.M.), Medicinal Chemistry (B.S.R., J.C.D., R.A.T.), and Pediatrics (J.R.P., D.S.H.), University of Washington, Seattle, Washington; Divisions of Clinical Research (B.S.R., J.R.P., D.S.H., J.S.M.) and Public Health Sciences (S.S.T., K.W.M.), Fred Hutchinson Cancer Research Center, Seattle, Washington; and Division of Hematology/Oncology, Seattle Children's Hospital, Seattle, Washington (J.R.P., D.S.H.)
- Address correspondence to:
Dr. Rheem A. Totah, University of Washington, Box 357610, Seattle, WA 98195-7610. E-mail: rtotah{at}u.washington.edu
This work was previously presented as follows: Raccor BS, Claessens AJ, Dinh JC, Thomas SS, Makar KW, McCune JS, and Totah RA (2011) Potential contributions of cytochrome P450 2B6 to 4-hydroxycyclophosphamide formation in vitro. Drug Metabolism Gordon Research Conference; 2011 Jul 10–15; Holderness, NH. University of Washington, Seattle, Washington.
J.S.M. and R.A.T. contributed equally to this work.